KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Cash from Restructuring (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Cash from Restructuring data on record, last reported at $8.0 million in Q4 2025.

  • For Q4 2025, Cash from Restructuring rose 366.67% year-over-year to $8.0 million; the TTM value through Dec 2025 reached -$7.0 million, down 113.73%, while the annual FY2025 figure was -$7.0 million, 113.73% down from the prior year.
  • Cash from Restructuring reached $8.0 million in Q4 2025 per CL's latest filing, up from -$2.0 million in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $81.0 million in Q1 2022 and bottomed at -$22.0 million in Q3 2022.
  • Average Cash from Restructuring over 5 years is $2.4 million, with a median of -$2.5 million recorded in 2021.
  • Peak YoY movement for Cash from Restructuring: tumbled 450.0% in 2022, then skyrocketed 1900.0% in 2024.
  • A 5-year view of Cash from Restructuring shows it stood at -$2.0 million in 2021, then changed by 0.0% to -$2.0 million in 2022, then plummeted by 200.0% to -$6.0 million in 2023, then surged by 50.0% to -$3.0 million in 2024, then surged by 366.67% to $8.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Restructuring were $8.0 million in Q4 2025, -$2.0 million in Q3 2025, and -$6.0 million in Q2 2025.